| Year |
Citation |
Score |
| 2017 |
Shan KQ, Lubenov EV, Siapas AG. Model-based spike sorting with a mixture of drifting t-distributions. Journal of Neuroscience Methods. PMID 28652008 DOI: 10.1016/J.Jneumeth.2017.06.017 |
0.481 |
|
| 2016 |
Shan KQ, Lubenov EV, Papadopoulou M, Siapas AG. Spatial tuning and brain state account for dorsal hippocampal CA1 activity in a non-spatial learning task. Elife. 5. PMID 27487561 DOI: 10.7554/Elife.14321 |
0.564 |
|
| 2016 |
Shan KQ, Lubenov EV, Papadopoulou M, Siapas AG. Author response: Spatial tuning and brain state account for dorsal hippocampal CA1 activity in a non-spatial learning task Elife. DOI: 10.7554/Elife.14321.020 |
0.554 |
|
| Low-probability matches (unlikely to be authored by this person) |
| 2012 |
Brand J, Kruczek N, Shan K, Haraf P, Simmons DE. Climbing for credit: applying Kurt Hahn's principles for promoting holistic lifestyles. Holistic Nursing Practice. 26: 103-5. PMID 22343932 DOI: 10.1097/HNP.0b013e31824733a3 |
0.049 |
|
| 2023 |
Sandborn WJ, Vermeire S, Peyrin-Biroulet L, Dubinsky MC, Panes J, Yarur A, Ritter T, Baert F, Schreiber S, Sloan S, Cataldi F, Shan K, Rabbat CJ, Chiorean M, Wolf DC, et al. Etrasimod as induction and maintenance therapy for ulcerative colitis (ELEVATE): two randomised, double-blind, placebo-controlled, phase 3 studies. Lancet (London, England). PMID 36871574 DOI: 10.1016/S0140-6736(23)00061-2 |
0.045 |
|
| 2016 |
Halseth A, Shan K, Walsh B, Gilder K, Fujioka K. Method-of-use study of naltrexone sustained release (SR)/bupropion SR on body weight in individuals with obesity. Obesity (Silver Spring, Md.). PMID 28026920 DOI: 10.1002/oby.21726 |
0.031 |
|
| 2009 |
Ravussin E, Smith SR, Mitchell JA, Shringarpure R, Shan K, Maier H, Koda JE, Weyer C. Enhanced weight loss with pramlintide/metreleptin: an integrated neurohormonal approach to obesity pharmacotherapy. Obesity (Silver Spring, Md.). 17: 1736-43. PMID 19521351 DOI: 10.1038/Oby.2009.184 |
0.024 |
|
| 2017 |
Guerdjikova AI, Walsh B, Shan K, Halseth AE, Dunayevich E, McElroy SL. Concurrent Improvement in Both Binge Eating and Depressive Symptoms with Naltrexone/Bupropion Therapy in Overweight or Obese Subjects with Major Depressive Disorder in an Open-Label, Uncontrolled Study. Advances in Therapy. PMID 28918581 DOI: 10.1007/s12325-017-0613-9 |
0.02 |
|
| 2022 |
Vyas R, Gohel A, Escoffier C, Shan K, Katz J. Idiopathic lingual mandibular sequestration and its relationship to medication-related osteonecrosis of the jaws (MRONJ): mini review. Quintessence International (Berlin, Germany : 1985). 868-873. PMID 36169274 DOI: 10.3290/j.qi.b3418171 |
0.018 |
|
| 2014 |
Herrmann K, Shan K, Brunell SC, Chen S. Effects of pramlintide in patients with type 2 diabetes mellitus: an analysis using daily insulin dose tertiles. Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists. 20: 1070-5. PMID 25100363 DOI: 10.4158/EP13477.OR |
0.01 |
|
| 2013 |
Herrmann K, Frias JP, Edelman SV, Lutz K, Shan K, Chen S, Maggs D, Kolterman OG. Pramlintide improved measures of glycemic control and body weight in patients with type 1 diabetes mellitus undergoing continuous subcutaneous insulin infusion therapy. Postgraduate Medicine. 125: 136-44. PMID 23748514 DOI: 10.3810/pgm.2013.05.2635 |
0.01 |
|
| 2012 |
Malloy J, Gurney K, Shan K, Yan P, Chen S. Increased variability and abnormalities in pancreatic enzyme concentrations in otherwise asymptomatic subjects with type 2 diabetes. Diabetes, Metabolic Syndrome and Obesity : Targets and Therapy. 5: 419-24. PMID 23269874 DOI: 10.2147/DMSO.S34241 |
0.01 |
|
| Hide low-probability matches. |